WKN: | 927079 |
ISIN: | US4523271090 |
Land: | USA |
Branche: | Chemie, Pharma, Bio- & Medizintechnik |
Sektor: | Medizintechnik |
Weshalb die Illumina-Aktie
ein D-Rating hat,
erfahren Sie im Performance-Check
vom 10. September 2025 Info.
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2006 | 6,10 | 14,88 | 143,93% |
2 | 2010 | 21,27 | 48,09 | 126,09% |
3 | 2013 | 42,40 | 81,48 | 92,17% |
4 | 2014 | 81,48 | 154,20 | 89,25% |
5 | 2003 | 1,55 | 2,92 | 88,39% |
6 | 2012 | 22,93 | 42,40 | 84,91% |
7 | 2005 | 3,32 | 6,10 | 83,73% |
8 | 2017 | 121,76 | 180,70 | 48,41% |
9 | 2018 | 180,70 | 262,26 | 45,14% |
10 | 2007 | 14,88 | 20,03 | 34,61% |
11 | 2009 | 17,81 | 21,27 | 19,43% |
12 | 2015 | 154,20 | 176,50 | 14,46% |
13 | 2004 | 2,92 | 3,32 | 13,70% |
14 | 2019 | 262,26 | 298,10 | 13,67% |
15 | 2021 | 299,35 | 333,30 | 11,34% |
16 | 2024 | 127,68 | 128,32 | 0,50% |
17 | 2020 | 298,10 | 299,35 | 0,42% |
18 | 2008 | 20,03 | 17,81 | -11,08% |
19 | 2016 | 176,50 | 121,76 | -31,01% |
20 | 2023 | 185,52 | 127,68 | -31,18% |
Rang | Datum | Vorjahr | Schluss | Performance |
---|---|---|---|---|
1 | 2002 | 6,50 | 1,55 | -76,15% |
2 | 2011 | 48,09 | 22,93 | -52,32% |
3 | 2022 | 333,30 | 185,52 | -44,34% |
4 | 2025 | 128,32 | 83,18 | -35,18% |
5 | 2023 | 185,52 | 127,68 | -31,18% |
6 | 2016 | 176,50 | 121,76 | -31,01% |
7 | 2008 | 20,03 | 17,81 | -11,08% |
8 | 2020 | 298,10 | 299,35 | 0,42% |
9 | 2024 | 127,68 | 128,32 | 0,50% |
10 | 2021 | 299,35 | 333,30 | 11,34% |
11 | 2019 | 262,26 | 298,10 | 13,67% |
12 | 2004 | 2,92 | 3,32 | 13,70% |
13 | 2015 | 154,20 | 176,50 | 14,46% |
14 | 2009 | 17,81 | 21,27 | 19,43% |
15 | 2007 | 14,88 | 20,03 | 34,61% |
16 | 2018 | 180,70 | 262,26 | 45,14% |
17 | 2017 | 121,76 | 180,70 | 48,41% |
18 | 2005 | 3,32 | 6,10 | 83,73% |
19 | 2012 | 22,93 | 42,40 | 84,91% |
20 | 2003 | 1,55 | 2,92 | 88,39% |